CAL.Regulation
California requires gene synthesis equipment makers and providers to follow federal screening framework
Governor Gavin Newsom signed AB 1864 on September 30, 2026. From January 1, 2027, manufacturers of benchtop nucleic acid synthesis equipment and providers of specified synthetic nucleic acids may not produce in California or sell or deliver to California customers unless they adhere to the federal Framework for Nucleic Acid Synthesis Screening, as revised in September 2024, and publicly post an attestation of compliance.
Enrolled text (California Legislative Information) → · Office of Governor Gavin Newsom
Key points
- AB 1864 adds Chapter 1.5, commencing with Health and Safety Code section 24200, effective January 1, 2027.California Legislative Information
- Benchtop nucleic acid synthesis equipment makers must adhere to the federal screening framework, attest compliance and post the attestation online to sell in California.California Legislative Information
- Providers of specified synthetic nucleic acids face the same adherence, attestation and public-posting requirements to produce or sell to California customers.California Legislative Information
- The governing framework is the National Science and Technology Council committee's September 2024 Framework for Nucleic Acid Synthesis Screening.California Legislative Information
- Violations carry civil penalties scaled to severity of up to $5,000 for each day a violation continues.California Legislative Information
- Newsom signed AB 1864 on September 30, 2026, as part of a package of AI and technology bills.Office of Governor Gavin Newsom
Sources2 articles across 2 outlets
California Legislative Information
Office of Governor Gavin Newsom
Filed under
RegulationCal.California AB 1864 gene synthesis safetyComplianceHealthcareRegulatoryFor governanceFor vendors